Invention Grant
- Patent Title: Anti-GM-CSF antibodies and uses thereof
-
Application No.: US15744734Application Date: 2017-09-18
-
Publication No.: US10647767B2Publication Date: 2020-05-12
- Inventor: Zhengyi Wang , Lei Fang , Bingshi Guo , Jingwu Zang
- Applicant: I-Mab-Biopharma Co., Ltd.
- Applicant Address: CN Shanghai
- Assignee: I-Mab Biopharma Co., Ltd.
- Current Assignee: I-Mab Biopharma Co., Ltd.
- Current Assignee Address: CN Shanghai
- Agency: Sheppard Mullin Richter & Hampton LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@338569f6 com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@495ca15d
- International Application: PCT/CN2017/102057 WO 20170918
- International Announcement: WO2018/050111 WO 20180322
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/395 ; C07K16/24 ; A61P19/02 ; A61P29/00 ; A61P35/02 ; A61P37/02 ; A61P37/06 ; A61P35/00 ; G01N33/68
Abstract:
Provided are anti-GM-CSF antibodies or fragments thereof including humanized antibodies and fragments. Also provided are uses of the antibodies and fragments for therapeutic, diagnostic and prognostic purposes. Therapeutic uses of the antibodies and fragments, for example include the treatment of inflammatory and autoimmune diseases and disorders.
Public/Granted literature
- US20190002549A1 ANTI-GM-CSF ANTIBODIES AND USES THEREOF Public/Granted day:2019-01-03
Information query
